Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Primoris Services
PRIM
$4.35B
| $10.7M | ﹤0.01% |
137,909
+15,648
| +13% | +$1.06M |
|
1527
StoneCo
STNE
$2.52B
| $10.7M | ﹤0.01% |
669,091
+166,239
| +33% | +$2.22M |
|
1528
Radian Group
RDN
$4.87B
| $10.7M | ﹤0.01% |
297,213
+76,918
| +35% | +$2.57M |
|
1529
Qfin Holdings
QFIN
$1.59B
| $10.7M | ﹤0.01% |
246,520
+136,329
| +124% | +$5.68M |
|
1530
HF Sinclair
DINO
$15.2B
| $10.7M | ﹤0.01% |
260,040
+63,062
| +32% | +$2.17M |
|
1531
Merit Medical Systems
MMSI
$5.36B
| $10.7M | ﹤0.01% |
114,038
-15,831
| -12% | -$1.5M |
|
1532
Insperity
NSP
$1.96B
| $10.7M | ﹤0.01% |
177,304
+30,457
| +21% | +$2.13M |
|
1533
LCI Industries
LCII
$2.55B
| $10.6M | ﹤0.01% |
116,781
-69,369
| -37% | -$5.92M |
|
1534
New Jersey Resources
NJR
$5.45B
| $10.6M | ﹤0.01% |
237,484
+66,752
| +39% | +$3.13M |
|
1535
Planet Fitness
PLNT
$3.7B
| $10.6M | ﹤0.01% |
97,536
+50,277
| +106% | +$5.03M |
|
1536
Southern Copper
SCCO
$167B
| $10.6M | ﹤0.01% |
109,775
+44,417
| +68% | +$3.86M |
|
1537
Tandem Diabetes Care
TNDM
$1.59B
| $10.6M | ﹤0.01% |
567,072
+53,066
| +10% | +$1.05M |
|
|
RNAM
1538
DELISTED
Avidity Biosciences
RNAM
| $10.6M | ﹤0.01% |
371,770
+47,875
| +15% | +$1.43M |
|
1539
PUT
CrowdStrike
CRWD
$229B
| $10.5M | ﹤0.01% |
82,800
-121,200
| -59% | -$13.1M |
|
1540
CALL
Applovin
APP
$113B
| $10.5M | ﹤0.01% |
30,100
-52,400
| -64% | -$17M |
|
1541
Ormat Technologies
ORA
$6.87B
| $10.5M | ﹤0.01% |
125,639
+41,882
| +50% | +$3.13M |
|
1542
Construction Partners
ROAD
$6.71B
| $10.5M | ﹤0.01% |
98,904
+34,757
| +54% | +$3.25M |
|
1543
OneMain Financial
OMF
$7.27B
| $10.5M | ﹤0.01% |
184,364
-12,256
| -6% | -$611K |
|
1544
US Foods
USFD
$23.9B
| $10.5M | ﹤0.01% |
136,130
+176
| +0.1% | +$12.6K |
|
1545
ICICI Bank
IBN
$108B
| $10.5M | ﹤0.01% |
311,050
+46,790
| +18% | +$1.55M |
|
|
VRNA
1546
DELISTED
Verona Pharma
VRNA
| $10.5M | ﹤0.01% |
110,611
+1,110
| +1% | +$82.2K |
|
1547
Ameris Bancorp
ABCB
$5.88B
| $10.5M | ﹤0.01% |
161,631
+51,242
| +46% | +$3.04M |
|
1548
Knife River
KNF
$3.83B
| $10.5M | ﹤0.01% |
128,034
+37,713
| +42% | +$3.43M |
|
1549
Mercury Systems
MRCY
$6.52B
| $10.4M | ﹤0.01% |
193,468
+40,681
| +27% | +$1.98M |
|
1550
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
| $10.4M | ﹤0.01% |
+175,400
| New | +$9.77M |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.